MK-1942, A NEGATIVE ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTOR 2, FOR TREATMENTRESISTANT DEPRESSION

被引:0
|
作者
Merola, Aristide [1 ]
Mukai, Yuki [1 ]
Bueters, Tjerk [1 ]
Ceesay, Paulette [1 ]
Dupre, Nicole [1 ]
Furtek, Christine [1 ]
Sanacora, Gerard [1 ]
Thase, Michael [1 ]
Targum, Steven D. [1 ]
Alexopoulou, Zoi [1 ]
Mahon, Chantal [1 ]
Li, Wenping [1 ]
Miller, Callie [1 ]
Yee, Kelly [1 ]
Smith, Sean M. [1 ]
Uslaner, Jason [1 ]
Stoch, Aubrey [1 ]
Egan, Michael [1 ]
机构
[1] Merck & Co Inc, Rahway, NJ 07065 USA
关键词
Treatment Resistant Depression; Metabotropic glutamate receptor 2 (mGluR2); randomized clinical trial;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P648
引用
收藏
页码:440 / 441
页数:2
相关论文
共 50 条
  • [1] Chemical Switch of a Metabotropic Glutamate Receptor 2 Silent Allosteric Modulator into Dual Metabotropic Glutamate Receptor 2/3 Negative/Positive Allosteric Modulators
    Schann, Stephan
    Mayer, Stanislas
    Franchet, Christel
    Frauli, Melanie
    Steinberg, Edith
    Thomas, Mireille
    Baron, Luc
    Neuville, Pascal
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (24) : 8775 - 8779
  • [2] Radiosynthesis and evaluation of a negative allosteric modulator for the PET imaging of metabotropic glutamate receptor 2 in rat brain
    Kumata, Katsushi
    Zhang, Yiding
    Hatori, Akiko
    Yamasaki, Tomoteru
    Kurihara, Yusuke
    Nengaki, Nobuki
    Zhang, Ming-Rong
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S395 - S396
  • [3] Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 500 - 501
  • [4] Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator
    Rosenbrock, Holger
    Kramer, Gert
    Hobson, Scott
    Koros, Eliza
    Grundl, Marc
    Grauert, Matthias
    Reymann, Klaus G.
    Schroeder, Ulrich H.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) : 40 - 46
  • [5] Characterization of the Clinical Effect of a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor-2
    De Boer, Peter
    Sinha, Vikash
    Hoeben, Eva
    Anghelescu, Ion-George
    Kezic, Iva
    Daly, Ella
    Ceusters, Marc
    De Smedt, Heidi
    Van Nueten, Luc
    Kent, Justine M.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 319S - 319S
  • [6] Computational Analysis of Negative and Positive Allosteric Modulator Binding and Function in Metabotropic Glutamate Receptor 5 (In)Activation
    Dalton, James A. R.
    Gomez-Santacana, Xavier
    Llebaria, Amadeu
    Giraldo, Jesus
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (05) : 1476 - 1487
  • [7] In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor
    Beggiato, Sarah
    Borelli, Andrea C.
    Tomasini, Maria C.
    Castelli, M. Paola
    Pintori, Nicholas
    Cacciaglia, Roberto
    Loche, Antonella
    Ferraro, Luca
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [8] Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5
    Fuxe, Kjell
    Borroto-Escuela, Dasiel O.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (09) : 1247 - 1260
  • [9] The discovery of RG1578: a metabotropic glutamate receptor 2/3 negative allosteric modulator with antidepressant and cognitive enhancing properties
    Gatti, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S278 - S279
  • [10] VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy
    Nickols, Hilary Highfield
    Yuh, Joannes P.
    Gregory, Karen J.
    Morrison, Ryan D.
    Bates, Brittney S.
    Stauffer, Shaun R.
    Emmitte, Kyle A.
    Bubser, Michael
    Peng, Weimin
    Nedelcovych, Michael T.
    Thompson, Analisa
    Lv, Xiaohui
    Xiang, Zixiu
    Daniels, J. Scott
    Niswender, Colleen M.
    Lindsley, Craig W.
    Jones, Carrie K.
    Conn, P. Jeffrey
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (01): : 123 - 136